nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Progesterone—uterine cancer	0.155	0.236	CbGbCtD
Palonosetron—CYP2D6—Progesterone—uterine cancer	0.128	0.195	CbGbCtD
Palonosetron—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.123	0.187	CbGbCtD
Palonosetron—CYP3A4—Progesterone—uterine cancer	0.0813	0.124	CbGbCtD
Palonosetron—CYP1A2—Etoposide—uterine cancer	0.0695	0.106	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—uterine cancer	0.039	0.0594	CbGbCtD
Palonosetron—CYP3A4—Etoposide—uterine cancer	0.0364	0.0554	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—uterine cancer	0.0248	0.0378	CbGbCtD
Palonosetron—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000885	0.00258	CcSEcCtD
Palonosetron—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00257	CcSEcCtD
Palonosetron—Hiccups—Epirubicin—uterine cancer	0.000881	0.00257	CcSEcCtD
Palonosetron—Anaemia—Dactinomycin—uterine cancer	0.000877	0.00256	CcSEcCtD
Palonosetron—Injection site reaction—Epirubicin—uterine cancer	0.000876	0.00255	CcSEcCtD
Palonosetron—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000874	0.00255	CcSEcCtD
Palonosetron—Dyskinesia—Doxorubicin—uterine cancer	0.000867	0.00253	CcSEcCtD
Palonosetron—Abdominal pain—Progesterone—uterine cancer	0.000866	0.00252	CcSEcCtD
Palonosetron—Body temperature increased—Progesterone—uterine cancer	0.000866	0.00252	CcSEcCtD
Palonosetron—Hyperkalaemia—Epirubicin—uterine cancer	0.000865	0.00252	CcSEcCtD
Palonosetron—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00252	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.0025	CcSEcCtD
Palonosetron—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000856	0.0025	CcSEcCtD
Palonosetron—Salivary hypersecretion—Epirubicin—uterine cancer	0.000856	0.00249	CcSEcCtD
Palonosetron—Influenza like illness—Epirubicin—uterine cancer	0.000856	0.00249	CcSEcCtD
Palonosetron—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00247	CcSEcCtD
Palonosetron—Fluid retention—Epirubicin—uterine cancer	0.000836	0.00244	CcSEcCtD
Palonosetron—Hepatobiliary disease—Etoposide—uterine cancer	0.000831	0.00242	CcSEcCtD
Palonosetron—Hiccups—Doxorubicin—uterine cancer	0.000815	0.00238	CcSEcCtD
Palonosetron—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000812	0.00237	CcSEcCtD
Palonosetron—Injection site reaction—Doxorubicin—uterine cancer	0.00081	0.00236	CcSEcCtD
Palonosetron—Myalgia—Dactinomycin—uterine cancer	0.000808	0.00235	CcSEcCtD
Palonosetron—Hypersensitivity—Progesterone—uterine cancer	0.000808	0.00235	CcSEcCtD
Palonosetron—Hyperkalaemia—Doxorubicin—uterine cancer	0.000801	0.00233	CcSEcCtD
Palonosetron—Discomfort—Dactinomycin—uterine cancer	0.000798	0.00233	CcSEcCtD
Palonosetron—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000792	0.00231	CcSEcCtD
Palonosetron—Influenza like illness—Doxorubicin—uterine cancer	0.000792	0.00231	CcSEcCtD
Palonosetron—Asthenia—Progesterone—uterine cancer	0.000786	0.00229	CcSEcCtD
Palonosetron—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.00229	CcSEcCtD
Palonosetron—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.00229	CcSEcCtD
Palonosetron—Urinary tract disorder—Etoposide—uterine cancer	0.000779	0.00227	CcSEcCtD
Palonosetron—Pruritus—Progesterone—uterine cancer	0.000775	0.00226	CcSEcCtD
Palonosetron—Fluid retention—Doxorubicin—uterine cancer	0.000774	0.00225	CcSEcCtD
Palonosetron—Urethral disorder—Etoposide—uterine cancer	0.000774	0.00225	CcSEcCtD
Palonosetron—Infection—Dactinomycin—uterine cancer	0.00077	0.00224	CcSEcCtD
Palonosetron—Diarrhoea—Progesterone—uterine cancer	0.00075	0.00219	CcSEcCtD
Palonosetron—Anorexia—Dactinomycin—uterine cancer	0.000738	0.00215	CcSEcCtD
Palonosetron—Eye disorder—Etoposide—uterine cancer	0.000738	0.00215	CcSEcCtD
Palonosetron—Cardiac disorder—Etoposide—uterine cancer	0.000732	0.00213	CcSEcCtD
Palonosetron—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.00213	CcSEcCtD
Palonosetron—Dizziness—Progesterone—uterine cancer	0.000725	0.00211	CcSEcCtD
Palonosetron—Angiopathy—Etoposide—uterine cancer	0.000716	0.00209	CcSEcCtD
Palonosetron—Immune system disorder—Etoposide—uterine cancer	0.000713	0.00208	CcSEcCtD
Palonosetron—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000713	0.00208	CcSEcCtD
Palonosetron—Mediastinal disorder—Etoposide—uterine cancer	0.000711	0.00207	CcSEcCtD
Palonosetron—Chills—Etoposide—uterine cancer	0.000708	0.00206	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000706	0.00206	CcSEcCtD
Palonosetron—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000703	0.00205	CcSEcCtD
Palonosetron—Alopecia—Etoposide—uterine cancer	0.000697	0.00203	CcSEcCtD
Palonosetron—Vomiting—Progesterone—uterine cancer	0.000697	0.00203	CcSEcCtD
Palonosetron—Rash—Progesterone—uterine cancer	0.000691	0.00201	CcSEcCtD
Palonosetron—Dermatitis—Progesterone—uterine cancer	0.00069	0.00201	CcSEcCtD
Palonosetron—Headache—Progesterone—uterine cancer	0.000687	0.002	CcSEcCtD
Palonosetron—Hot flush—Epirubicin—uterine cancer	0.000684	0.00199	CcSEcCtD
Palonosetron—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00068	0.00198	CcSEcCtD
Palonosetron—Menopausal symptoms—Epirubicin—uterine cancer	0.000678	0.00197	CcSEcCtD
Palonosetron—Decreased appetite—Dactinomycin—uterine cancer	0.000673	0.00196	CcSEcCtD
Palonosetron—Dysgeusia—Etoposide—uterine cancer	0.000673	0.00196	CcSEcCtD
Palonosetron—Fatigue—Dactinomycin—uterine cancer	0.000668	0.00195	CcSEcCtD
Palonosetron—Pain—Dactinomycin—uterine cancer	0.000662	0.00193	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000661	0.00193	CcSEcCtD
Palonosetron—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000657	0.00191	CcSEcCtD
Palonosetron—Nausea—Progesterone—uterine cancer	0.000651	0.0019	CcSEcCtD
Palonosetron—Pain in extremity—Epirubicin—uterine cancer	0.000639	0.00186	CcSEcCtD
Palonosetron—Anaemia—Etoposide—uterine cancer	0.000635	0.00185	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000633	0.00185	CcSEcCtD
Palonosetron—Hot flush—Doxorubicin—uterine cancer	0.000632	0.00184	CcSEcCtD
Palonosetron—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000631	0.00184	CcSEcCtD
Palonosetron—Menopausal symptoms—Doxorubicin—uterine cancer	0.000627	0.00183	CcSEcCtD
Palonosetron—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00182	CcSEcCtD
Palonosetron—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00182	CcSEcCtD
Palonosetron—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000622	0.00181	CcSEcCtD
Palonosetron—Abdominal pain—Dactinomycin—uterine cancer	0.000612	0.00178	CcSEcCtD
Palonosetron—Body temperature increased—Dactinomycin—uterine cancer	0.000612	0.00178	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000611	0.00178	CcSEcCtD
Palonosetron—Convulsion—Etoposide—uterine cancer	0.000595	0.00173	CcSEcCtD
Palonosetron—Hypertension—Etoposide—uterine cancer	0.000593	0.00173	CcSEcCtD
Palonosetron—Pain in extremity—Doxorubicin—uterine cancer	0.000592	0.00172	CcSEcCtD
Palonosetron—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00059	0.00172	CcSEcCtD
Palonosetron—Abdominal pain upper—Epirubicin—uterine cancer	0.000584	0.0017	CcSEcCtD
Palonosetron—Hypokalaemia—Epirubicin—uterine cancer	0.000582	0.0017	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000581	0.00169	CcSEcCtD
Palonosetron—Discomfort—Etoposide—uterine cancer	0.000578	0.00168	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000576	0.00168	CcSEcCtD
Palonosetron—Hypersensitivity—Dactinomycin—uterine cancer	0.000571	0.00166	CcSEcCtD
Palonosetron—Gastritis—Epirubicin—uterine cancer	0.000566	0.00165	CcSEcCtD
Palonosetron—Anaphylactic shock—Etoposide—uterine cancer	0.000561	0.00163	CcSEcCtD
Palonosetron—Infection—Etoposide—uterine cancer	0.000557	0.00162	CcSEcCtD
Palonosetron—Abdominal distension—Epirubicin—uterine cancer	0.000556	0.00162	CcSEcCtD
Palonosetron—Asthenia—Dactinomycin—uterine cancer	0.000556	0.00162	CcSEcCtD
Palonosetron—Tachycardia—Etoposide—uterine cancer	0.000547	0.00159	CcSEcCtD
Palonosetron—Skin disorder—Etoposide—uterine cancer	0.000545	0.00159	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—uterine cancer	0.00054	0.00157	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—uterine cancer	0.000538	0.00157	CcSEcCtD
Palonosetron—Anorexia—Etoposide—uterine cancer	0.000534	0.00156	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000533	0.00155	CcSEcCtD
Palonosetron—Diarrhoea—Dactinomycin—uterine cancer	0.00053	0.00154	CcSEcCtD
Palonosetron—Hypotension—Etoposide—uterine cancer	0.000524	0.00153	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—uterine cancer	0.000524	0.00153	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—uterine cancer	0.000515	0.0015	CcSEcCtD
Palonosetron—Paraesthesia—Etoposide—uterine cancer	0.000503	0.00147	CcSEcCtD
Palonosetron—Dyspnoea—Etoposide—uterine cancer	0.0005	0.00146	CcSEcCtD
Palonosetron—Hyperglycaemia—Epirubicin—uterine cancer	0.000499	0.00145	CcSEcCtD
Palonosetron—Somnolence—Etoposide—uterine cancer	0.000498	0.00145	CcSEcCtD
Palonosetron—Vomiting—Dactinomycin—uterine cancer	0.000493	0.00144	CcSEcCtD
Palonosetron—Rash—Dactinomycin—uterine cancer	0.000488	0.00142	CcSEcCtD
Palonosetron—Decreased appetite—Etoposide—uterine cancer	0.000487	0.00142	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Etoposide—uterine cancer	0.000484	0.00141	CcSEcCtD
Palonosetron—Fatigue—Etoposide—uterine cancer	0.000483	0.00141	CcSEcCtD
Palonosetron—Pain—Etoposide—uterine cancer	0.000479	0.0014	CcSEcCtD
Palonosetron—Constipation—Etoposide—uterine cancer	0.000479	0.0014	CcSEcCtD
Palonosetron—Hepatobiliary disease—Epirubicin—uterine cancer	0.000466	0.00136	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—uterine cancer	0.000465	0.00135	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—uterine cancer	0.000462	0.00135	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—uterine cancer	0.000461	0.00134	CcSEcCtD
Palonosetron—Nausea—Dactinomycin—uterine cancer	0.00046	0.00134	CcSEcCtD
Palonosetron—Gastrointestinal pain—Etoposide—uterine cancer	0.000458	0.00134	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—uterine cancer	0.00045	0.00131	CcSEcCtD
Palonosetron—Body temperature increased—Etoposide—uterine cancer	0.000443	0.00129	CcSEcCtD
Palonosetron—Abdominal pain—Etoposide—uterine cancer	0.000443	0.00129	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—uterine cancer	0.000437	0.00127	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—uterine cancer	0.000435	0.00127	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—uterine cancer	0.000434	0.00126	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000431	0.00126	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—uterine cancer	0.00043	0.00125	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—uterine cancer	0.000428	0.00125	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—uterine cancer	0.000417	0.00121	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—uterine cancer	0.000413	0.0012	CcSEcCtD
Palonosetron—Hypersensitivity—Etoposide—uterine cancer	0.000413	0.0012	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—uterine cancer	0.000412	0.0012	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—uterine cancer	0.000411	0.0012	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—uterine cancer	0.000404	0.00118	CcSEcCtD
Palonosetron—Asthenia—Etoposide—uterine cancer	0.000402	0.00117	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—uterine cancer	0.000402	0.00117	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—uterine cancer	0.000401	0.00117	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—uterine cancer	0.000401	0.00117	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—uterine cancer	0.0004	0.00116	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—uterine cancer	0.000399	0.00116	CcSEcCtD
Palonosetron—Chills—Epirubicin—uterine cancer	0.000397	0.00116	CcSEcCtD
Palonosetron—Pruritus—Etoposide—uterine cancer	0.000397	0.00116	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—uterine cancer	0.000395	0.00115	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—uterine cancer	0.000391	0.00114	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—uterine cancer	0.000388	0.00113	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—uterine cancer	0.000385	0.00112	CcSEcCtD
Palonosetron—Erythema—Epirubicin—uterine cancer	0.000385	0.00112	CcSEcCtD
Palonosetron—Diarrhoea—Etoposide—uterine cancer	0.000384	0.00112	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—uterine cancer	0.000383	0.00111	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—uterine cancer	0.000382	0.00111	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—uterine cancer	0.00038	0.00111	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—uterine cancer	0.000379	0.00111	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—uterine cancer	0.000377	0.0011	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—uterine cancer	0.000371	0.00108	CcSEcCtD
Palonosetron—Dizziness—Etoposide—uterine cancer	0.000371	0.00108	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—uterine cancer	0.00037	0.00108	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—uterine cancer	0.000369	0.00107	CcSEcCtD
Palonosetron—Chills—Doxorubicin—uterine cancer	0.000367	0.00107	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—uterine cancer	0.000366	0.00107	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—uterine cancer	0.000362	0.00105	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—uterine cancer	0.000359	0.00104	CcSEcCtD
Palonosetron—Vomiting—Etoposide—uterine cancer	0.000356	0.00104	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—uterine cancer	0.000356	0.00104	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—uterine cancer	0.000356	0.00104	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—uterine cancer	0.000356	0.00104	CcSEcCtD
Palonosetron—Rash—Etoposide—uterine cancer	0.000354	0.00103	CcSEcCtD
Palonosetron—Dermatitis—Etoposide—uterine cancer	0.000353	0.00103	CcSEcCtD
Palonosetron—Headache—Etoposide—uterine cancer	0.000351	0.00102	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—uterine cancer	0.000351	0.00102	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—uterine cancer	0.000349	0.00102	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—uterine cancer	0.000334	0.000972	CcSEcCtD
Palonosetron—Nausea—Etoposide—uterine cancer	0.000333	0.00097	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—uterine cancer	0.000332	0.000969	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—uterine cancer	0.000329	0.00096	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—uterine cancer	0.000328	0.000955	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—uterine cancer	0.000328	0.000955	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—uterine cancer	0.000327	0.000952	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000326	0.000949	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—uterine cancer	0.000324	0.000944	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—uterine cancer	0.000321	0.000934	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—uterine cancer	0.000314	0.000916	CcSEcCtD
Palonosetron—Infection—Epirubicin—uterine cancer	0.000312	0.00091	CcSEcCtD
Palonosetron—Shock—Epirubicin—uterine cancer	0.000309	0.000901	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—uterine cancer	0.000309	0.0009	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—uterine cancer	0.000308	0.000898	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—uterine cancer	0.000308	0.000896	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—uterine cancer	0.000307	0.000894	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—uterine cancer	0.000305	0.00089	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—uterine cancer	0.000303	0.000884	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—uterine cancer	0.000303	0.000884	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—uterine cancer	0.000302	0.000881	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000301	0.000878	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—uterine cancer	0.0003	0.000873	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—uterine cancer	0.0003	0.000873	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—uterine cancer	0.000297	0.000865	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—uterine cancer	0.000294	0.000856	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—uterine cancer	0.000291	0.000847	CcSEcCtD
Palonosetron—Infection—Doxorubicin—uterine cancer	0.000289	0.000842	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000286	0.000834	CcSEcCtD
Palonosetron—Shock—Doxorubicin—uterine cancer	0.000286	0.000834	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—uterine cancer	0.000285	0.000831	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—uterine cancer	0.000284	0.000828	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—uterine cancer	0.000284	0.000827	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—uterine cancer	0.000282	0.000823	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—uterine cancer	0.000282	0.000822	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—uterine cancer	0.00028	0.000816	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—uterine cancer	0.000279	0.000814	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—uterine cancer	0.000277	0.000808	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—uterine cancer	0.000277	0.000806	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—uterine cancer	0.000273	0.000796	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—uterine cancer	0.000272	0.000792	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000271	0.000791	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—uterine cancer	0.000271	0.00079	CcSEcCtD
Palonosetron—Constipation—Epirubicin—uterine cancer	0.000269	0.000783	CcSEcCtD
Palonosetron—Pain—Epirubicin—uterine cancer	0.000269	0.000783	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000265	0.000772	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—uterine cancer	0.000263	0.000766	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—uterine cancer	0.000261	0.000761	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—uterine cancer	0.000259	0.000755	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—uterine cancer	0.000259	0.000753	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—uterine cancer	0.000257	0.000749	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—uterine cancer	0.000256	0.000746	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—uterine cancer	0.000253	0.000737	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000251	0.000732	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—uterine cancer	0.000251	0.000731	CcSEcCtD
Palonosetron—Pain—Doxorubicin—uterine cancer	0.000249	0.000725	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—uterine cancer	0.000249	0.000725	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—uterine cancer	0.000248	0.000724	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—uterine cancer	0.000248	0.000724	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000238	0.000693	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—uterine cancer	0.000232	0.000675	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—uterine cancer	0.00023	0.00067	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—uterine cancer	0.00023	0.00067	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—uterine cancer	0.000225	0.000657	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—uterine cancer	0.000222	0.000648	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—uterine cancer	0.000215	0.000627	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—uterine cancer	0.000214	0.000624	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—uterine cancer	0.000209	0.000608	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—uterine cancer	0.000208	0.000606	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—uterine cancer	0.000206	0.0006	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—uterine cancer	0.0002	0.000582	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—uterine cancer	0.000199	0.00058	CcSEcCtD
Palonosetron—Rash—Epirubicin—uterine cancer	0.000198	0.000577	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—uterine cancer	0.000198	0.000577	CcSEcCtD
Palonosetron—Headache—Epirubicin—uterine cancer	0.000197	0.000574	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—uterine cancer	0.000192	0.00056	CcSEcCtD
Palonosetron—Nausea—Epirubicin—uterine cancer	0.000187	0.000544	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—uterine cancer	0.000185	0.000539	CcSEcCtD
Palonosetron—Rash—Doxorubicin—uterine cancer	0.000183	0.000534	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—uterine cancer	0.000183	0.000534	CcSEcCtD
Palonosetron—Headache—Doxorubicin—uterine cancer	0.000182	0.000531	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—uterine cancer	0.000173	0.000503	CcSEcCtD
